Tamoxifen 98%
Proveedor: Thermo Fisher Scientific
|
Peligro
|
J63509.ME
J63509.03
J63509.06
J63509.MEEA
155
EUR
J63509.ME
J63509.03
J63509.06
Tamoxifen 98%
Tamoxifen
Inhibitor of protein kinase C and induces apoptosis in cancer cells.
Tamoxifen is used in the treatment of both early and advanced estrogen receptor positive breast cancer in pre- and post-menopausal women. It is also used in the treatment of infertility in women with anovulatory disorders as well as to prevent estrogen-related gynecomastia. It is utilized in the study on lipopolysaccharide (LPS)-induced microglial activation to know its effect.
Applications: Inhibitor of protein kinase C and induces apoptosis in cancer cells
Formula:
C₂₆H₂₉NO |
Número MDL:
MFCD00010454 Núm. CAS: 10540-29-1 EINECS: 234-118-0 Índice Merck: 14,9048 |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...